News Agency
Men's Weekly

GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

  • Written by PR Newswire

R&D Innovation to Lead the Future, Deepening Customer Value Creation

  • Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at an impressive 30%, with a strong global operation and stable cash flow. In 2023, the group's best-in-class cell therapy product CARVYKTI®, achieved sales exceeding $500 million, becoming the...

Read more: GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

Steps to Take When Facing a Commercial Lease Dispute in Australia

A commercial lease dispute can disrupt business operations, especially when the business premises are central to generating revenue. This article outlines practical steps to take when a disagreement arises under a commercial lease in Australia and how, as a tenant, you can... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion